A significant number of genes were amplified in greater than 30 percent of cancer patients, including DCUN1D1 (43% of lung squamous cancers), FADD and PPFIA1 (∼30% of head and neck cancers), and PRKCI (36% of lung squamous cancers) (Fig. S4). This evidence concerns the gene FADD and head and neck cancer.